Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

BioMarin Pharma Reaches Agreement On Reimbursement Amount For ROCTAVIAN In Germany

Por: RTTNews Health November 28, 2023

thumbnail

BioMarin Pharmaceutical Inc. () announced an agreement with the German National Association of Statutory Health Insurance Funds on the reimbursement amount for ROCTAVIAN for people with severe hemophilia A. The company noted that this is the first gene therapy for hemophilia to receive an agreed federal price in Germany. BioMarin and GKV-SV have agreed on an outcome-based prospective cohort model for ROCTAVIAN. The agreement, with a minimum term... + full article



Similar News

$2.9 million gene therapy for severe hemophilia is approved by FDA

WPLG Local 10 USA Health June 30, 2023

thumbnailWASHINGTON – U.S. officials on Thursday approved drugmaker BioMarin's gene therapy for the most common form of hemophilia, a $2.9 million infused treatment that can significantly reduce dangerous bleeding problems.The Food and Drug Administration approved Roctavian for... + más

Gene therapy can transform life for people with hemophilia. But some patients don’t want it. | The Boston Globe

FDA approves most expensive drug ever, $3.5 million-per-dose gene therapy for hemophilia B | CBS News


Gene therapy for severe hemophilia is approved by FDA

ABC News USA Business June 29, 2023

thumbnailWASHINGTON -- U.S. officials on Thursday approved drugmaker BioMarin's gene therapy for the most common form of hemophilia, an infused treatment that can significantly reduce dangerous bleeding problems.The Food and Drug Administration approved Roctavian for adult patients... + más

Gene therapy can transform life for people with hemophilia. But some patients don’t want it. | The Boston Globe

FDA approves most expensive drug ever, $3.5 million-per-dose gene therapy for hemophilia B | CBS News


Gene therapy for severe hemophilia is approved by FDA

ABC News USA Health June 29, 2023

thumbnailWASHINGTON -- U.S. officials on Thursday approved drugmaker BioMarin's gene therapy for the most common form of hemophilia, an infused treatment that can significantly reduce dangerous bleeding problems.The Food and Drug Administration approved Roctavian for adult patients... + más

Gene therapy can transform life for people with hemophilia. But some patients don’t want it. | The Boston Globe

FDA approves most expensive drug ever, $3.5 million-per-dose gene therapy for hemophilia B | CBS News


High school scores and top performers from Tuesday, March 28

Orlando Sentinel USA Sports March 29, 2023

thumbnailLake Brantley 9, Seminole 6 (8 inn.) Buzz: Jackson Golden went 2-for-5 with 2 home runs and 6 RBI for Lake Brantley. Ben Colley had a home run. Bryce Carter had 2 hits for Seminole. Mount Dora Christian Academy 10, Oak Hall (Gainesville) 4 Buzz: Collin Priest went 5-for-5 with a... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


High school scores and top performers from Friday, March 24

Orlando Sentinel USA Sports March 25, 2023

thumbnailOrangewood Christian 11, The Master’s Academy 1 Buzz: Austin Waring threw 5 innings of 1-run ball (0 earned runs) while allowing 4 hits and striking out 8 for Orangewood Christian. He lowered his season ERA to 0.78. Aiden McKee went 3-for-3 with a double, a walk, an RBI and a... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


High school scores and top performers from Tuesday, March 7

Orlando Sentinel USA Sports March 08, 2023

thumbnailThe Master’s Academy 12, Lake Highland Prep 0 Buzz: Jackson Bellhorn pitched a complete game with 8 strikeouts for Master’s. Colby Cason went 1-for-2 with 2 RBI, Trey Seluk went 1-for-3 with a double and 2 RBI. Joey Talbot pitched 3 innings striking out 4 for the... + más

NFL Playoff Scenarios | ABC News

Le Krewe du Roi celebrates the state at 58th annual Mardi Gras Ball | The Advocate


Netflix, Workday, Costco, Caterpillar and more: These stocks are Cowen's favorites for 2023

MarketWatch USA Business December 10, 2022

thumbnailBut that’s not the whole bull case: “Cigna trades at the lowest multiple in [its] group, has the second-lowest percentage of sell-side buy ratings and its key fundamental risk (recession unemployment) is most overtly/visibly discounted by the market.” Costco Wholesale... + más

Why You Should Buy Costco’s Latest Kirkland Signature Scotch Whisky Releases | Forbes

Giant moth with baby xenomorph skull face horrifies the internet | Newsweek



About iurex | Privacy Policy | Disclaimer |